RedHill Biopharma reported $7.1M in Interest Income for its fiscal quarter ending in June of 2023.





Interest Income Change Date
Compugen USD 954K 116K Sep/2025
Cronos Group USD 9M 668K Jun/2025
RedHill Biopharma USD 7.1M 14.49M Jun/2023